Confirmation on the immunogenicity assay used in the SB4 phase III study: Response to the comments by Meacci et al

Emery, P, Vencovský, J, Kang, JW et al. (1 more author) (2016) Confirmation on the immunogenicity assay used in the SB4 phase III study: Response to the comments by Meacci et al. Annals of the Rheumatic Diseases, 75 (7). e40. ISSN 0003-4967

Metadata

Authors/Creators:
  • Emery, P
  • Vencovský, J
  • Kang, JW
  • Ghil, J
Copyright, Publisher and Additional Information: © 2016, BMJ Publishing Group Ltd and the European League Against Rheumatism. This is an author produced version of a paper published in Annals of the Rheumatic Diseases. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 22 April 2016
  • Published (online): 17 May 2016
  • Published: July 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Sep 2016 10:05
Last Modified: 14 Apr 2017 04:38
Published Version: http://dx.doi.org/10.1136/annrheumdis-2016-209696
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/annrheumdis-2016-209696

Export

Statistics


CORE (COnnecting REpositories)